Calcitonin
A hormone made by special 'C-cells' in the thyroid gland. Its main clinical use is as a tumour marker: a raised calcitonin is a signal of medullary thyroid cancer (a rare thyroid cancer arising from these cells), used to help diagnose it and to monitor for recurrence after treatment.
What it measures
Calcitonin is a hormone produced by the parafollicular or 'C-cells' of the thyroid gland; it has a minor role in calcium regulation, but its importance in testing is quite different. Its main clinical use is as a tumour marker for medullary thyroid cancer — an uncommon type of thyroid cancer that arises specifically from these C-cells and overproduces calcitonin. Measuring blood calcitonin therefore helps in three ways. First, it aids diagnosis: a clearly raised level in someone with a thyroid nodule raises the suspicion of medullary thyroid cancer. Second, once such a cancer is treated (usually by surgery), calcitonin is followed over time as a sensitive way to detect any recurrence — a level that stays low is reassuring, while a rising level signals the cancer may have returned. Third, it is used in screening families with the inherited form of the disease (part of the MEN2 syndromes), where relatives carrying the gene may be checked. Calcitonin can also be mildly raised for non-cancer reasons (such as kidney impairment or certain medications), so a modestly high result is interpreted carefully and usually rechecked, not assumed to mean cancer.
What a high value can mean
- Medullary thyroid cancer — the key concern; a clearly raised level, especially with a thyroid nodule, points toward this cancer.
- A rising level after treatment — suggests the cancer may have recurred; used for monitoring.
- Inherited (MEN2) forms — relevant when screening gene-carrying family members.
- Non-cancer causes of a mild rise — kidney impairment, certain medications (e.g. proton-pump inhibitors), smoking — so a modest elevation is interpreted with care.
What a low value can mean
- A low or normal level — the expected, reassuring result.
- A persistently low level after treatment of medullary thyroid cancer — reassuring, suggesting no detectable recurrence.
When to discuss with a doctor
Calcitonin is a specialist test rather than a routine one, used mainly around medullary thyroid cancer. It may be checked when a thyroid nodule is being assessed, and it is central to monitoring after treatment of a confirmed medullary thyroid cancer, where the trend over time is what matters — a stable low level is reassuring, a rising level prompts further imaging. It is also used to screen relatives in families with the inherited (MEN2) form. Because a modest rise can have non-cancer causes, a borderline result is interpreted carefully and usually rechecked rather than taken at face value. This needs specialist assessment by endocrinology. Mediora.AI surfaces a calcitonin result alongside the related thyroid markers so the pattern is visible; the interpretation and any next steps belong with your specialist team.